Methylene blue treatment in experimental ischemic stroke: A mini-review

Stroke is among the leading causes of death and long-term disability. Methylene blue (MB), a drug grandfathered by the Food and Drug Administration with a long history of safe usage in humans for treating methemoglobinemia and cyanide poisoning, has recently been shown to be neuroprotective in neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Zhao, Duong, Timothy Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817094/
https://www.ncbi.nlm.nih.gov/pubmed/27042692
http://dx.doi.org/10.4103/2394-8108.178548
_version_ 1782424838394085376
author Jiang, Zhao
Duong, Timothy Q
author_facet Jiang, Zhao
Duong, Timothy Q
author_sort Jiang, Zhao
collection PubMed
description Stroke is among the leading causes of death and long-term disability. Methylene blue (MB), a drug grandfathered by the Food and Drug Administration with a long history of safe usage in humans for treating methemoglobinemia and cyanide poisoning, has recently been shown to be neuroprotective in neurodegenerative diseases and brain injuries. The goal of this paper is to review studies on MB in experimental stroke models.
format Online
Article
Text
id pubmed-4817094
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-48170942016-04-01 Methylene blue treatment in experimental ischemic stroke: A mini-review Jiang, Zhao Duong, Timothy Q Brain Circ Review Article Stroke is among the leading causes of death and long-term disability. Methylene blue (MB), a drug grandfathered by the Food and Drug Administration with a long history of safe usage in humans for treating methemoglobinemia and cyanide poisoning, has recently been shown to be neuroprotective in neurodegenerative diseases and brain injuries. The goal of this paper is to review studies on MB in experimental stroke models. Medknow Publications & Media Pvt Ltd 2016 2016-03-11 /pmc/articles/PMC4817094/ /pubmed/27042692 http://dx.doi.org/10.4103/2394-8108.178548 Text en Copyright: © 2016 Brain Circulation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Review Article
Jiang, Zhao
Duong, Timothy Q
Methylene blue treatment in experimental ischemic stroke: A mini-review
title Methylene blue treatment in experimental ischemic stroke: A mini-review
title_full Methylene blue treatment in experimental ischemic stroke: A mini-review
title_fullStr Methylene blue treatment in experimental ischemic stroke: A mini-review
title_full_unstemmed Methylene blue treatment in experimental ischemic stroke: A mini-review
title_short Methylene blue treatment in experimental ischemic stroke: A mini-review
title_sort methylene blue treatment in experimental ischemic stroke: a mini-review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817094/
https://www.ncbi.nlm.nih.gov/pubmed/27042692
http://dx.doi.org/10.4103/2394-8108.178548
work_keys_str_mv AT jiangzhao methylenebluetreatmentinexperimentalischemicstrokeaminireview
AT duongtimothyq methylenebluetreatmentinexperimentalischemicstrokeaminireview

Ejemplares similares